Prohibix, LLC
Injectable biotherapeutics to rejuvenate aging tissues.
Philadelphia, United States · Founded 2018
- Headquarters
- Philadelphia, Pennsylvania
- Employees
- 1–10
- Founded
- 2018
- Business Model
- B2B
- Website
- prohibix.com
About
Prohibix is an early-stage biotech company developing injectable biotherapeutics to rejuvenate aging tissues and halt degenerative diseases. Its HYALUTE™ microparticle platform enables long-acting tissue lubrication, anti-inflammatory activity, and controlled drug release. The technology was spun out of Dr. Jason Burdick's lab at the University of Pennsylvania, targeting conditions such as osteoarthritis, cardiovascular disease, and chronic ulcers.
Summary
Prohibix, LLC is a Biotech company based in Philadelphia, United States, founded in 2018.
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/prohibix-llc"><img src="https://indexed.vc/api/badge/company/prohibix-llc" alt="Prohibix, LLC on Indexed.vc" width="260" height="76" /></a>